Chelation therapy in Wegener's granulomatosis. Treatment with EDTA.
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002481:Cellulitis / Q000188:drug therapy*; D003300:Copper / Q000652:urine; D003638:Deafness / Q000209:etiology; D004492:Edetic Acid / Q000627:therapeutic use*; D005128:Eye Diseases / Q000188:drug therapy*; D005260:Female; D014890:Granulomatosis with Polyangiitis / Q000188:drug therapy*; D006801:Humans; D009461:Neurologic Manifestations; D009667:Nose Deformities, Acquired / Q000209:etiology; D009886:Ophthalmoplegia / Q000209:etiology; D010033:Otitis Media / Q000188:drug therapy*; D011166:Porphyrins / Q000652:urine; D011239:Prednisolone / Q000627:therapeutic use; D012877:Skin Manifestations; D014364:Tryptophan / Q000378:metabolism; D015032:Zinc / Q000652:urine
D000900:Anti-Bacterial Agents; D011166:Porphyrins; D003300:Copper; D014364:Tryptophan; D004492:Edetic Acid; D011239:Prednisolone; D015032:Zinc